Agilon Health, Inc.
Market Cap
$254.73M
P/E Ratio
-0.63
EPS
$-0.98
Dividend Yield
0.00%
52-Week Range
$0.34 — $6.08
Volume
1.76M
Avg Volume
6.68M
Beta
0.11
P/E (TTM)
-0.63
Forward P/E
—
PEG Ratio
0.02
P/S (TTM)
0.04
P/B (TTM)
1.96
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-1.17%
ROA (TTM)
-0.31%
ROIC
—
Gross Margin
-0.03%
Operating Margin
-0.07%
Net Margin
—
Debt/Equity
0.29
Current Ratio
1.02
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-0.23%
EPS Growth (5Y)
-1.14%
Sales Growth (3Y)
+0.59%
Sales Growth (5Y)
+0.51%
EPS Est (This Year)
$-0.23
EPS Est (Next Year)
$-0.18
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$0.69
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
414.58M
Float
268.58M
Free Float %
64.78%
RSI (14)
68.44
SMA 20
$0.50
SMA 50
$0.70
SMA 200
$1.14
ATR (14)
0.08
Volatility (Week)
0.12%
Volatility (Month)
0.12%
Pattern
—
1 Day
+0.27%
1 Week
-2.53%
1 Month
-5.00%
3 Months
-17.60%
6 Months
-50.01%
1 Year
—
YTD
-10.94%
All-Time High
$6.08
Sector
Healthcare
Industry
Medical - Care Facilities
Country
US
Exchange
NYSE
IPO Date
2021-04-15
Employees
1076
CEO
Ronald Allan Williams
Index Membership
—
Website
https://agilonhealth.com
Agilon Health, Inc. (AGL) is a healthcare company in the medical - care facilities industry listed on the NYSE. With a market capitalization of $254.73M, a P/E ratio of -0.63, AGL is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare AGL against other stocks using dozens of fundamental and technical filters.
Agilon Health, Inc. (AGL) has a trailing twelve-month (TTM) P/E ratio of -0.63. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Agilon Health, Inc. (AGL) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Agilon Health, Inc. (AGL) has a market capitalization of $254.73 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Agilon Health, Inc. (AGL) has returned -10.94% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.